No Data
No Data
Shisi Pharmaceutical Group (02005) has obtained drug production registration approval for linezolid dry suspension (5ml: 100mg)
Shisi Pharmaceutical Group (02005) issued an announcement. The group has obtained the relevant linezolamide dry mix from the China National Drug Administration...
Shi Siyao Group (02005.HK) was increased by 1 million shares by executive director Qu Jiguang
Gelonghui, April 19丨According to the latest equity disclosure data of the Stock Exchange, on April 18, 2024, Shijiyao Group (02005.HK) obtained an increase of 1 million shares by Executive Director Qu Jiguang at an average price of HK$4.6752 per share on the market, involving approximately HK$4.6752 million. After increasing his holdings, Qu Jiguang's latest shareholding was 1,117,706,000 shares, and the shareholding ratio increased from 37.61% to 37.65%.
Shisi Pharmaceutical Group (02005.HK): Performance is in line with expectations, net profit margin increased year-on-year
The 1Q24 results are in line with our expectations. The company announced 1Q24 results: revenue of HK$1,799 million, up 2.9% year on year (approximately 6.7% in RMB caliber); net profit to mother of HK$416 million, corresponding to zero profit per share
石四藥集團:2023 年報
Shi Siyao Group (02005.HK) obtained 800,000 shares from executive director Qu Jiguang
Gelonghui, April 18 | According to the latest equity disclosure data of the Stock Exchange, on April 17, 2024, Shijiyao Group (02005.HK) obtained executive director Qu Jiguang's holdings of 800,000 shares on the market at an average price of HK$4.763 per share, involving approximately HK$3.8104 million. After increasing his holdings, Qu Jiguang's latest shareholding was 1,116,706,000 shares, and the shareholding ratio increased from 37.58% to 37.61%.
Shisi Pharmaceutical Group (02005.HK) received 800,000 additional shares of common stock worth approximately HK$3,810,400 from China Pharmaceutical Company Limited
On April 17, it was reported that according to documents disclosed by the Hong Kong Stock Exchange on April 17, China Pharmaceutical Company Limited increased its share holdings of $800,000 in $Shihsiyao Group (02005.HK) with an average price of HK$4.763 per share on April 17, worth about HK$3.8104 million. After the increase in holdings, China Pharmaceutical Company Limited's latest shareholding was 832 million shares, and the good position ratio rose from 27.98% to 28.01%. graphs
No Data